Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations.
Zahra MeshkaniAli AboutorabiNajmeh MoradiMostafa LangarizadehAli Ghanbari MotlaghPublished in: Hereditary cancer in clinical practice (2021)
The genetic BRCA tests for the general population as well as unselected breast cancer patients were cost-effective in high and upper-middle income countries and those with prevalence of gene mutation while population-based genetic tests for low-middle income countries are depended on the price of the tests.